In 2023, it was estimated that Australia's medical device market was valued at 5.62 billion U.S. dollars. The market size is the total local production and imports minus exports.

Australia's medical and scientific equipment market is heavily reliant on imports, with imports valued at $19.4 billion in 2022-23, nearly doubling the domestic manufacturing revenue of $10.4 billion. Wholesalers are crucial in distributing diverse equipment from countries like the United States, Germany, Switzerland and China, catering to various downstream markets, including mining, manufacturing, hospitals and laboratories. Growing health expenditure, fuelled by a $112.7 billion allocation in the 2024-25 Federal Budget and an ageing population, has increased demand for medical equipment. Technological advancements in medical equipment and significant capital projects, like the $1.5 billion hospital in Footscray, have further boosted wholesaler activity, leading to industrywide revenue climbing at an annualised 3.9% over the five years through 2024-25 to total $25.0 billion. Even so, intense internal competition and wholesale bypass challenge wholesalers, as buyers increasingly purchase directly from manufacturers to reduce costs. Technological advancements have enabled downstream markets to source products directly, pressuring wholesalers to lower prices to retain customers. Climbing transport costs have also squeezed profit margins, leading to slumps in profitability. The extensive range of specialist products and markets results in low industry concentration, with most wholesalers focusing on niche areas within medical and scientific equipment wholesaling. Over the coming years, innovation in medical technology, an ageing population and rising public health expenditure will contribute to industry expansion. Advances in medical equipment, like robotic surgical technology and innovative monitoring devices, will drive demand for new equipment imported and distributed by wholesalers. The population aged 70 and over is projected to grow substantially through 2029-30, boosting demand for health services and related medical equipment. Substantial government investment in healthcare funding will enable hospitals and medical centres to upgrade and expand their equipment inventories, contributing to industrywide revenue climbing at an estimated annualised rate of 2.7% through 2029-30, reaching $28.5 billion. Wholesalers must enhance their services and invest in customer support to maintain profitability and compete with threats like manufacturers bringing wholesaling in-house.

Australia Reprocessed Medical Devices Market size was valued at around USD 319 million in 2024 and is projected to reach USD 506 million by 2030 along with a CAGR of around 8%.

Medical and surgical equipment manufacturers are thriving, with Australia's ageing population and expanding healthcare sector boosting domestic demand for medical and surgical equipment. Sales surged in 2020-21, with revenue rising 31.6% owing to pandemic-induced demand for medical and surgical equipment like ventilators, infusion systems and renal care products used in intensive care units to treat the virus across private and public hospitals. While demand for these goods strengthened, restrictions on elective surgeries hit sales of other products like dental equipment and hearing aids. Overall, industry revenue is anticipated to have grown at an annualised 4.2% over the past five years and is expected to total $7.3 billion in 2024-25, when revenue will climb by an estimated 0.9%. The upswing in sales hasn't been entirely a result of the pandemic – manufacturers can also thank the high-tech medical equipment they make. Technological advances and ongoing investment in research and development have allowed manufacturers to offer the latest medical and surgical equipment to downstream markets, keeping them at the forefront of innovation and fuelling industry sales. Industry profitability has performed well through 2024-25. Although starting from a low base, industry profitability has been bolstered by strong public health spending, which has enabled manufacturers to sustain their margins. Going forwards, Australia's ageing population and greater investment in health care are set to drive demand for medical and surgical equipment. Manufacturers will continue to invest in R&D, which will help promote product innovation and create new revenue streams. Advancements in specialised products among local manufacturers are set to drive demand from export markets. The Australian Government's Medical Science Co-Investment Plan will shine the spotlight on medical science manufacturing, with advances in robotics and smart devices set to drive an upswing in medical device manufacturing. Strong public health expenditure will underpin expanding industry revenue, which is forecast to climb at an annualised 2.1% over the five years through 2029-30 to total $8.1 billion.

The revenue in the 'Medical Devices' segment of the medical technology market in Australia & Oceania was forecast to continuously increase between 2024 and 2029 by in total 3.1 billion U.S. dollars (+38.04 percent). After the ninth consecutive increasing year, the revenue is estimated to reach 11.27 billion U.S. dollars and therefore a new peak in 2029. Find further information concerning the revenue in the medical technology market in the United States and the revenue in the medical technology market in Haiti. The Statista Market Insights cover a broad range of additional markets.

Australia Reprocessed Medical Devices Market size growing with CAGR of 7.1% in the Forecast period & it crosses USD 782.5 Mn by 2032 from USD 484.1 Mn in 2025.

Australia Wearable Medical Devices Market is driven by advancements in technology, an emphasis on preventive healthcare, and the growing prevalence of chronic diseases.

Employment statistics on the Medical and Surgical Equipment Manufacturing industry in Australia

The Australian general surgical devices market is a dynamic sector experiencing steady growth, projected to maintain a Compound Annual Growth Rate (CAGR) of 2.00% from 2025 to 2033. While the exact market size in 2025 is unavailable, we can reasonably estimate its value based on global trends and the provided CAGR. Considering similar markets and projected growth, a plausible estimate for the 2025 market size in Australia could be in the range of AUD 250-300 million. This growth is fueled by several factors: an aging population necessitating more surgical procedures, advancements in minimally invasive surgical techniques (driving demand for laparoscopic and handheld devices), and increasing prevalence of chronic diseases requiring surgical intervention. The market is segmented by product type (handheld devices, laparoscopic devices, electrosurgical devices, wound closure devices, trocars and access devices, and other products) and application (gynecology and urology, cardiology, orthopedics, neurology, and other applications). The strong presence of established multinational companies like Medtronic, Stryker, Olympus, Conmed, Johnson & Johnson, B. Braun, and Boston Scientific indicates a mature market with robust competition and ongoing innovation. However, market growth may be constrained by factors such as high costs associated with advanced surgical devices, stringent regulatory approvals, and potential reimbursement challenges within the Australian healthcare system. The increasing adoption of robotic surgery could also influence market dynamics, potentially impacting demand for certain traditional devices in the long term. Nevertheless, the favorable demographic trends, technological advancements in minimally invasive surgery, and the ongoing commitment to healthcare infrastructure upgrades in Australia are expected to propel the growth of the general surgical devices market throughout the forecast period. Specific segments like laparoscopic devices and electrosurgical devices are poised for faster growth compared to others due to their wide applicability across different surgical specialties. Recent developments include: In August 2022, CMR Surgical has established partnerships with two tele-mentoring businesses, Teladoc Health and SurgEase Innovations Ltd, to improve continuous training support for surgical teams using the Versius Surgical Robotic System., In June 2022, Nova Eye Medical, a medical device firm, has begun shipping its new iTrack Advance surgical device for use in glaucoma surgery to surgeons.. Key drivers for this market are: Rising Demand for Minimally Invasive Devices, Growing Cases of Injuries and Accidents. Potential restraints include: Stringent Government Regulations, Improper Reimbursement for Surgical Devices. Notable trends are: Handheld Device is Expected to Dominate the General Surgical Devices Market.

The report on Australia Reprocessed Medical Devices covers a summarized study of several factors supporting market growth, such as market size, market type, major regions, and end-user applications. The report enables customers to recognize key drivers that influence and govern the market.

In Australia Cardiovascular Medical Device Market, was valued at approximately USD 10.11 billion in 2022 and is projected to reach USD 12.45 billion by 2029, registering a Compound Annual Growth Rate (CAGR) of 8.65% during the forecast period.

Australia Ophthalmic Device Market size was valued at USD 1.88 Billion in 2024 and is projected to reach USD 2.8 Billion by 2031, growing at a CAGR of 5.5% from 2024 to 2031.

Australia Ophthalmic Device Market Drivers

Increasing Prevalence of Age-Related Eye Disorders: The aging population in Australia is a key driver of the ophthalmic device market. According to the Australian Bureau of Statistics, the population aged 65 and up is expected to grow from 15.9% in 2020 to 22.2% in 2030. According to the National Health and Medical Research Council, roughly 170,000 Australians suffer from age-related macular degeneration (AMD), which is anticipated to increase to 220,000 by 2025. Furthermore, the Australian Institute of Health and Welfare reported that glaucoma affects 300,000 Australians, with half of cases going untreated, increasing the demand for better ophthalmic diagnostic and treatment technology. Technological Advances and Government Healthcare Innovation: The Australian government's commitment to medical technology innovation is considerably boosting the ophthalmic device sector. The Department of Health and Aged Care has been aggressively supporting medical device innovation through its Medical Research Future Fund, which will provide AUD 480 million for medical technology research in 2022. The Therapeutic Goods Administration (TGA) has simplified the regulatory procedure for novel medical devices, resulting in a 35% increase in ophthalmic device approvals over the last three years. Rising Prevalence of Diabetes and Associated Eye Complications: The increasing incidence of diabetes in Australia is driving significant growth in the ophthalmic device market. The Australian Institute of Health and Welfare reports that 1.3 million Australians have diabetes, with diabetic retinopathy affecting approximately 30% of diabetes patients. The National Diabetes Services Scheme indicates that diabetic eye complications are a leading cause of preventable blindness, with over 75,000 new cases of diabetic retinopathy diagnosed annually.

The Australia 3D printing medical devices market was valued at USD 136.73 Million in 2024, driven are the growing demand for patient-specific implants and prosthetics and increasing government and private investments in healthcare innovation and additive manufacturing in the region. The market is anticipated to grow at a CAGR of 15.80% during the forecast period of 2025-2034, with the values likely to reach USD 592.86 Million by 2034. The market is further supported by the increasing adoption of personalized healthcare solutions and integration of 3D printing in surgical planning. Advancements in biocompatible materials and rising collaboration between research institutions and medtech firms are expected to fuel growth during the forecast period.

Australia’s aging population and growing prevalence of chronic diseases have created demand for customized implants and prosthetics that enhance patient comfort and reduce surgical complications. 3D printing allows clinicians to produce anatomically accurate devices tailored to individual patients, improving treatment outcomes, particularly in orthopedics, maxillofacial surgery, and dental applications. In addition, Australian hospitals are integrating 3D printing technologies into pre-surgical planning, enabling surgeons to rehearse complex procedures using 3D-printed anatomical models. These models improve accuracy, reduce operation times, and enhance patient safety, thereby boosting market growth.

The Australia and New Zealand wearable medical devices market size is expected to grow at a CAGR of 6.52% during the forecast period of 2025-2034, driven by the increasing advancements in wearable technologies, along with rising partnerships to increase their application across multiple fields.

Australia Respiratory Care Devices Market is anticipated to reach an exponential growth in the upcoming five years. Australia Respiratory Care Devices Market - Industry Size, Share, Trends, Competition, Opportunity and Forecast 2027 By Product Type, By Indication, By End User, By Region, Competition Forecast & Opportunities, 2027

Comprehensive dataset of 199 Medical equipment manufacturers in Australia as of June, 2025. Includes verified contact information (email, phone), geocoded addresses, customer ratings, reviews, business categories, and operational details. Perfect for market research, lead generation, competitive analysis, and business intelligence. Download a complimentary sample to evaluate data quality and completeness.

The Australian neonatal and prenatal devices market is experiencing steady growth, driven by factors such as rising birth rates, increasing prevalence of premature births and low birth weight infants, and advancements in medical technology leading to the development of sophisticated and less invasive devices. The market, valued at approximately $XX million in 2025 (assuming a logical market size based on global trends and the provided CAGR), is projected to expand at a Compound Annual Growth Rate (CAGR) of 4.50% from 2025 to 2033. This growth is fueled by increasing government initiatives to improve maternal and child healthcare infrastructure, along with rising awareness among parents about the importance of prenatal and postnatal care. Key segments within the market, such as prenatal equipment (including ultrasound and fetal monitoring devices) and neonatal equipment (such as incubators and respiratory support systems), are witnessing significant demand. The market's growth, however, faces potential restraints like the high cost of advanced medical devices and the limited reimbursement policies in some healthcare settings. Major players like GE Healthcare, Getinge AB, Koninklijke Philips NV, Natus Medical Incorporated, Vyaire Medical, Medtronic PLC, and Masimo (among others) are actively contributing to market expansion through continuous innovation and strategic partnerships. These companies are focusing on developing cutting-edge devices with enhanced features, improved accuracy, and user-friendliness to cater to the growing demand. Furthermore, the increasing adoption of telemedicine and remote patient monitoring technologies is expected to further drive market expansion, particularly in geographically dispersed regions of Australia. The historical period of 2019-2024 provided a baseline for assessing market growth and predicting future trends, with 2025 serving as the base year for forecasting to 2033. Future market analysis will continue to focus on these key drivers, restraints, and the evolving technological landscape. Recent developments include: August 2021: Australian startup ResusRight has raised nearly USD 784,000 to fund a pediatric medical device designed to resuscitate newborn babies safely., July 2021: I-MED Radiology, Australia's leading medical imaging company, agreed to use MRI Online's education and talent management platform for a multi-year period. Thus, such educational training programs are expected to support newborn babies efficiently.. Key drivers for this market are: Rising Incidence of Preterm Births, Increasing Awareness for Prenatal and Neonatal Care. Potential restraints include: Rising Incidence of Preterm Births, Increasing Awareness for Prenatal and Neonatal Care. Notable trends are: Incubators Sub-segment Expected to Hold a Significant Market Share.

The Australian and New Zealand Diagnostic Imaging Equipment Market Report is Segmented by Modality (MRI, Computed Tomography, Ultrasound, X-Ray, Nuclear Imaging, Fluoroscopy, and Mammography), Application (Cardiology, Oncology, Neurology, Orthopedics, Gastroenterology, Gynecology, and Other Applications), and End User (Hospital, Diagnostic Centers, and Other End Users). The Market Provides the Value (USD) for the Above Segments.

During 2023, the value of Australia's medical device imports is estimated to have reached over five billion U.S. dollars. In the same period, medical device exports were estimated to amount to just under two billion U.S. dollars.

In Australia Biopsy Devices Market, The market is growing steadily due to advancements in medical technology and the increasing demand for minimally invasive diagnostic procedures.